glp-1 clinical trials near me Obesity Glucagon-like peptide-1 receptor: mechanisms and

doi: 10.1016/S0140-6736(19)31149-3 255 HusainMBirkenfeldALDonsmarkMDunganKEliaschewitzFGFrancoDRet al

Gastrointestinal side effects affect up to 40% of people beginning GLP-1 agonist therapy, with diarrhea ranking among the most frequently reported

Supportive measures include electronic health record screening for food and nutrition security, curricular and accreditation interest in medical nutrition education, and expanded care pathways and reimbursement models [222]

Steering clear of greasy, fried, or heavily spiced foods, as well as carbonated drinks, can also reduce nausea and bloating

46 By enhancing HDAC6 through the GLP-1R-ERK1/2 pathway, GLP-1 treatment may inhibit the aberrant autophagy and inflammation caused by ROS